Study of TAK-733 in Adult Patients With Advanced Nonhematologic Malignancies

Clinical trial NCT00948467 · COMPLETED

Trial details

NCT number: NCT00948467
Sponsor: Millennium Pharmaceuticals, Inc.
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Advanced Non-hematologic Malignancies Advanced Metastatic Melanoma

Start date: 2009-12-01
Primary completion: 2013-04-01
Enrollment: 51

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.